Galapagos NV logo

Galapagos NV

BSP:G1LP34 (Belgium)  
R$ 8.65 (0%) Sep 22
P/E:
At Loss
P/B:
0.84
Market Cap:
R$ 570.03M ($ 115.50M)
Enterprise V:
R$ -19.76B ($ -4.00B)
Volume:
4.00
Avg Vol (2M):
37.00
Also Trade In:
Volume:
4.00
Market Cap R$:
570.03M
Market Cap $:
115.50M
PE Ratio:
At Loss
Avg Vol (2M):
37.00
Enterprise Value R$:
-19.76B
Enterprise Value $:
-4.00B
PB Ratio:
0.84

Business Description

Description
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.
Name Current Vs Industry Vs History
Cash-To-Debt 251.37
Equity-to-Asset 0.57
Debt-to-Equity 0.01
Debt-to-EBITDA -0.13
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.5
Distress
Grey
Safe
Beneish M-Score -1.91
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 8.42
9-Day RSI 16.05
14-Day RSI 22.92
6-1 Month Momentum % -3.76
12-1 Month Momentum % -19.06

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.49
Quick Ratio 8.38
Cash Ratio 8.16
Days Inventory 1046.61
Days Sales Outstanding 25.17
Days Payable 3736.91

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.6
Shareholder Yield % 0.27

Financials (Next Earnings Date:2023-11-02)

BSP:G1LP34's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Galapagos NV Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil R$) 3,021.695
EPS (TTM) (R$) -13.473
Beta 0
Volatility % 27.11
14-Day RSI 22.92
14-Day ATR (R$) 0.101827
20-Day SMA (R$) 9.035
12-1 Month Momentum % -19.06
52-Week Range (R$) 8.65 - 12.14
Shares Outstanding (Mil) 65.9

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Galapagos NV Filings

Filing Date Document Date Form
No Filing Data

Galapagos NV Stock Events

Event Date Price(R$)
No Event Data

Galapagos NV Frequently Asked Questions

What is Galapagos NV(BSP:G1LP34)'s stock price today?
The current price of BSP:G1LP34 is R$8.65. The 52 week high of BSP:G1LP34 is R$12.14 and 52 week low is R$8.65.
When is next earnings date of Galapagos NV(BSP:G1LP34)?
The next earnings date of Galapagos NV(BSP:G1LP34) is 2023-11-02.
Does Galapagos NV(BSP:G1LP34) pay dividends? If so, how much?
Galapagos NV(BSP:G1LP34) does not pay dividend.

Press Release

Subject Date
No Press Release